VICE PRESIDENT
AT ROCHE. THANKS FOR JOINING US. >> THANK YOU. >> AND SCIENTISTS AT ELI LILLY AND
COMPANY ARE ENGAGING IN THE WAR ON CORONAVIRUS...LILLY FORMING A NEW PARTNERSHIP WITH THE INDIANA STATE DEPARTMENT OF HEALTH, WITH
SUPPORT FROM THE FOOD AND DRUG ADMINISTRATION, TO ACCELERATE TESTING IN INDIANA. BUSINESS OF HEALTH REPORTER
KYLIE VELETA JOINS US NOW WITH MORE ON THAT STORY. KYLIE. >> THANK YOU, GERRY.
LILLY EXECUTIVES SAY THE PHARMACEUTICAL GIANT'S LABS THAT ARE TYPICALLY DEDICATED TO INTERNAL EXPERIMENTS ARE BEING
RE-PURPOSED TO HELP THE INDIANA STATE DEPARTMENT OF HEALTH ANALYZE TESTS FOR COVID-19...UP TO 2-THOUSAND PER DAY, WITH
TURNAROUND IN 4 TO 6 HOURS. THE ORGANIZATIONS SAY THIS IS TRULY UNIQUE NATIONWIDE; IT'S THE ONLY LARGE PUBLIC-PRIVATE PARTNERSHIP
FOR COVID TESTING THAT THEY'RE AWARE OF. ANALYZING TESTS FROM HEALTHCARE FACILITIES IS THE TOP PRIORITY: SUCH AS HOSPITALS, ERS
AND NURSING HOMES. LILLY IS ALSO PLANNING TO PILOT DRIVE-THRU TESTING FOR THE PUBLIC IN THE COMING DAYS ON LILLY PROPERTY.
ONE NOTE FROM ITS LEADERS: LILLY MAKES INSULIN HERE IN INDIANAPOLIS, AND IS STILL MAKING IT DURING THIS HEALTH
CRISIS. INSULIN IS A LIFE-SUSTAINING DRUG FOR PEOPLE WITH DIABETES, AND LILLY SAYS IT WILL CONTINUE TO PROVIDE AN
UNINTERRUPTED SUPPLY AND THERE'S NO NEED TO BUY AHEAD. AND THAT'S A MESSAGE THEY WANTED TO GET OUT TO THE PUBLIC.
>> AMAZING FROM ROCHE DIAGNOSTICS TO LILLY PULLING OUT THE STOPS. >> INDIANA PUBLIC HEALTH UP
UNTIL THIS POINT THEY'VE DONE OVER 200 TESTS, LILLY IS GOING TO BE ABLE TO TAKE THAT UP TO 2,000 PER DAY ONCE THEY REACH
FULL CAPACITY. ONE NOTE THAT ALL DEPENDS ON HAVING ACCESS TO REAGENTS, WHICH ARE CHEMICAL SUPPLIES THEY NEED TO PERFORM
THESE TESTS, AND THOSE ARE IN HIGH DEMAND RIGHT NOW. >> THIS HAS COST LILLY, THE COMPANY'S BEARING, NO COST --
>> CORRECT, THEY'RE DOING THIS FOR FREE, NO FUNDING FROM GOVERNMENT AGENCIES, HOSPITALS, PATIENTS, INSURANCE COMPANIES,